# Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients

> **NCT00744237** · PHASE4 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 231 (actual)

## Conditions studied

- Hypertension
- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Nebivolol
- **DRUG:** Metoprolol ER
- **DRUG:** HCTZ

## Key facts

- **NCT ID:** NCT00744237
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2010-07
- **Final completion:** —
- **Target enrollment:** 231 (ACTUAL)
- **Last updated:** 2011-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00744237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00744237, "Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00744237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*